LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2

BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Sehgal, Lalit, Jain, Neeraj, Khashab, Tamer, Mathur, Rohit, Samaniego, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175387/
https://www.ncbi.nlm.nih.gov/pubmed/27998273
http://dx.doi.org/10.1186/s12967-016-1100-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175387/
https://www.ncbi.nlm.nih.gov/pubmed/27998273
http://dx.doi.org/10.1186/s12967-016-1100-9

Ejemplares similares